Eli Lilly To Freeze Base Pay in 2012

0
Citing financial pressure from the loss of its patent on Zyprexa, Eli Lilly announced that it will freeze base pay for most of its...

First Personal Injury Lawsuit Over Risperdal Starts in New Jersey

0
Gary Skala's claim that 14 years of Risperdal caused his diabetes went to trial in New Jersey yesterday in the first personal injury lawsuit...

Assessing Increased Mortality Risks of Antipsychotics and Mood Stabilizers in Dementia

0
An article in January's American Journal of Psychiatry weighs the relative risk of mortality associated with various antipsychotics and mood stabilizers used in the treatment of...

Medications May Add to Mortality Rate in Schizophrenia

1
Dutch researchers write in the Journal of Clinical Psychopharmacology that, in a prospective study of 7415 persons with diagnoses of schizophrenia, use of a first-generation...

Discontinuing Psychotropics Reduces Falls in Elderly

0
Australian researchers look at the literature on the effect of psychotropics on falls in the elderly; largest effect of any randomized trial was achieved...

Antipsychotics Increase Retrovirus Activity in Humans

1
Endogenous retroviruses, remnants of ancient infections that have become part of the human genome, have been associated with the development of schizophrenia. But researchers...

J&J Earnings Down 89%

0
The Wall Street Journal reports that Johnson & Johnson's fourth-quarter earnings fell 89% following settlements for misrepresenting the risks and benefits of Risperdal, its...

Alarm About Antipsychotics as Sleep Aids

0
Canadian sleep researchers, writing in The Lancet, warn that weight gain, lipid and glucose dysregulation, restless leg syndrome, sleep-walking and eating while asleep, and...

Elevated Diabetes in Children Treated With Antipsychotics, Antidepressants

0
Researchers at the University of Massachusetts found that children are more than twice as likely to develop diabetes when treated with antidepressants, and more...

J&J Settles Texas Medicaid Lawsuit for $158 Million

0
Johnson & Johnson has agreed to settle Texas' lawsuit for the company's fraudulent marketing of Risperdal. The is the first time J&J has settled...

Texas Lawsuit Against J&J Underway

0
Texas' lawsuit against Johnson & Johnson for its off-label marketing of Risperdal, which the state alleges involved fraudulent claims about the drug's safety and...

J & J to Pay More Than $1 Billion For Wrongful Marketing of Risperdal

0
In order to resolve a civil investigation into the marketing of Risperdal for unapproved uses, Johnson & Johnson will pay more than $1 billion...

Antipsychotic Drugs and the Risk of Hyperglycemia in Older Adults Without Diabetes: A Population-Based...

0
  Objective: To determine whether current antipsychotic use among older persons without diabetes is associated with a higher risk of hospital visits for hyperglycemia, as...

Mad In America’s Chapters

2
Preface The World Health Organization has repeatedly found that people diagnosed with schizophrenia in the U.S. and other developed countries fare much worse than schizophrenia...

Antipsychotics and Chronic Illness

1
A. The Chronicity Problem Becomes Apparent (1960s-1979s) It seems paradoxical that drugs that ameliorate acute psychotic symptoms over the short term will increase the likelihood...

Polypharmacy/Bipolar illness

7
  A. Bipolar Illness Before the Psychopharmacology Era Prior to 1955, bipolar illness was a rare disorder. There were only 12,750 people  hospitalized with that disorder...

Outcomes in the Era of Atypical Antipsychotics

3
Once second-generation antipsychotic drugs came on the market (which are known as “atypicals”), there were claims by psychiatric researchers that they would lead to...

A Research Timeline for Antipsychotic Drugs

0
1883     Phenothiazines developed as synthetic dyes 1934     USDA develops phenothiazines as insecticides 1938     Phenothiazines used to kill swine parasites 1949  ...

A Rorschach Test for Psych Drugs

0
On October 23, the New York Times ran a very nice feature story about a Los Angeles woman, Keris Myrick, who, even though she...

Drug Companies ‘Just Say No’ to Psych Drugs

2
The market for psychiatric drugs is, of course,  booming. In 2011, spending on psychiatric medications can expect to top $40 billion. Yet, in spite...

”Broken Brains” and “Beautiful Minds”

0
When I first interviewed Brandon Banks, in the spring of 2008, while researching Anatomy of an Epidemic, he had recently entered Elizabethtown Community College...

A Schizophrenia Mystery Solved?

1
One of the enduring mysteries in schizophrenia research circles has been the disparity in outcomes between schizophrenia patients in "developing countries" and those in...

Antipsychotics/Schizophrenia

11
The long-term outcomes literature for antipsychotics, which has been compiled over a period of nearly 50 years, consistently tells of drugs that increase the...